Adlai Nortye Biopharma is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with our R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, they have built a global pipeline through collaborations and internal discovery with more than 10 drug candidates in development. They have assembled a world-class management team, built a unique immuno-oncology platforms and partnered with multiple top pharmaceutical companies to promote innovation.

Biotechnology

Adlai Nortye Biopharma

Paul Jiang

Yixiong Zhang

Sireesha Reddy Patlolla

Vicky W. Zhang

Xuyang Song, PhD, MBA

Victoria Demby (Maiden Thiel)

Wei HE

Justin Lucas

Peter Chen

Sandra Umbrecht

The Clinical Operations and Research team at Adlai Nortye Biopharma is responsible for overseeing the design, implementation, and management of clinical trials for oncology drugs. This cross-functional team ensures compliance with regulatory standards, coordinates between various stakeholders, and looks after patient safety. By collaborating closely with research and regulatory affairs, they work to advance innovative therapies through the clinical pipeline, ultimately aiming to improve patient outcomes in the field of oncology.

Clinical Operations and Research

Leadership Team

Human Resources and People Operations

Clinical Operations and Research

About

Team members

Other teams at Adlai Nortye Biopharma

Leadership Team

Human Resources and People Operations